查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842198

体液采集与诊断市场规模、份额及趋势分析报告：依样本、产品、技术、应用、地区及细分市场预测，2025-2033年

Body Fluid Collection And Diagnostics Market Size, Share & Trends Analysis Report By Sample (Blood, Saliva, Urine, Cerebrospinal Fluid), By Product (Tests/Services), By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

体液采集与诊断市场摘要

全球体液采集和诊断市场预计在 2024 年达到 343.5 亿美元，预计到 2033 年将达到 619.9 亿美元，2025 年至 2033 年的复合年增长率为 6.87%。

快速出结果、成本效益高、疾病早期预后好，这些都是推动体液采集和诊断产业发展的因素。

体外诊断技术的进步也发挥着重要作用，使检测更加准确高效，从而促进了其更广泛的应用。例如，2022年5月，TECHKON GmbH推出了一种新的体液分析方法，可同时评估各项医学参数并诊断疾病，使检测速度更快、更全面。

血液相关疾病的增加是推动血液采集设备需求成长的主要因素。贫血、镰状细胞贫血、血友病和凝血障碍等疾病以及骨髓瘤、淋巴瘤和白血病等血液癌症的发生率都在增加。在美国，血液癌症尤其具有毁灭性，平均每九分钟就有一人死于血液癌症，这意味着每天约有157人死亡，每小时超过六人死亡。预计到2023年，美国将有57,380人死于白血病、淋巴瘤和骨髓瘤，约占所有癌症相关死亡人数的9.4%。

据估计，美国约有437,337人患有白血病或处于白血病缓解期，约有879,242人患有淋巴瘤。血栓每年影响约90万美国人，并导致约10万人死亡。值得注意的是，只有不到四分之一的人会出现明显的血栓征兆或症状，这凸显了这种疾病的隐匿性及其带来的重大影响。

人们对疾病早期检测的日益关注显着推动了体液采集和诊断行业的需求。唾液、血液、尿液和精液等样本越来越多地被用于分析生物标记和其他指标，以实现准确及时的诊断。此外，全球范围内涌现许多技术进步和创新，进一步提升了检测能力，并拓展了基于体液诊断的疾病检测范围。例如，2021年7月，雅培宣布在印度推出Panbio COVID-19抗原自我检测试剂盒，进一步丰富了其快速诊断产品系列。本产品可满足职场、诊所和家庭的检测需求。最近，2024年5月，由Terumo Corporation开发的Rika血浆捐赠系统（采用iNomi列线图）获得美国FDA核准。本产品可根据捐赠者捐血时的体重、身高及血球比容值，以确定需要采集的血浆量。

阿兹海默症（AD）是一种严重的神经退化性疾病，因此亟需寻找准确的生物标记。早期生物标记的开发和检验是现有AD诊断方法的重要研究方向。体液生物标记能够准确反映大脑中的突触损伤，因此可能有助于提高诊断准确性、追踪疾病进程以及评估早期疾病修正治疗的疗效。 2022年5月，美国食品药物管理局（FDA）批准了一种可能改善AD诊断的新型检测方法上市。 Lumipulse检测评估人类脑脊髓液（CSF）中淀粉样蛋白1-40与淀粉样蛋白1-42的浓度比值，可以帮助医生判断患者是否有形成淀粉样蛋白的风险，而淀粉样蛋白斑块则是AD的标誌性症状。

体液样本中含有多种天然生物标记蛋白，这些蛋白质能够有效指示癌症的进展。体液样本也可用于检测这些生物标记，从而确诊癌症。例如，2022年1月，伊利诺大学的科学家开发了一种能够从体液样本中检测癌症生物标记的工具。对体液中此类癌症相关分子生物标记进行定量和检测，可能有助于实现微创癌症检测。

此外，体外诊断领域的技术创新，例如高通量检测、自动化和人工智慧的集成，正在显着提高诊断的准确性和效率。这些进步实现了更快的检测週期和更高的灵敏度，使体液诊断工具成为现代医疗保健中不可或缺的一部分。这些创新解决方案的出现正在推动这些技术在全球范围内的应用。

全球体液采集与诊断市场区隔

该报告预测了2021年至2033年全球、区域和国家层面的收入成长，并分析了各细分市场的产业趋势。为了便于研究，Grand View Research根据样本、技术、应用、产品和地区对全球体液采集和诊断市场报告进行了细分：

  • 按样本分類的展望（收入，2021-2033 年）
  • 血
  • 唾液
  • 尿
  • 脑脊髓液
  • 按产品分類的展望（收入，2021-2033 年）
  • 检查/服务
  • 套件和耗材
  • 检测设备
  • 按技术分類的展望（收入，2021-2033 年）
  • 下一代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • 萤光杂合反应萤光（FISH）
  • 其他的
  • 按应用领域分類的展望（收入，2021-2033 年）
  • 诊断和监测
  • 治疗决策
  • 预后诊断和筛检
  • 区域展望（收入，2021-2033 年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

目录

第一章调查方法和范围

第二章执行摘要

第三章 体液采集与诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 体液采集与诊断市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章 体液采集与诊断市场：样本估算与趋势分析

  • 按样本分類的市场份额，2024 年和 2033 年
  • 细分仪表板
  • 全球体液采集与诊断市场展望（依样本划分）
  • 市场规模、预测与趋势分析，2021-2033年
  • 血
  • 唾液
  • 尿
  • 脑脊髓液

第五章：体液采集与诊断市场：依产品分類的估算与趋势分析

  • 按产品分類的市场份额，2024 年和 2033 年
  • 细分仪表板
  • 全球体液采集与诊断市场展望（依产品划分）
  • 市场规模、预测与趋势分析，2021-2033年
  • 测试/服务
  • 套件和耗材
  • 装置

第六章：体液采集与诊断市场：依技术分類的估算与趋势分析

  • 按技术分類的市场份额，2024 年和 2033 年
  • 细分仪表板
  • 全球体液采集与诊断市场展望（依技术划分）
  • 市场规模、预测与趋势分析，2021-2033年
  • 次世代定序
  • 聚合酵素链锁反应（PCR）
  • 萤光杂合反应萤光（FISH）
  • 其他的

第七章：体液采集与诊断市场：按应用分類的估算与趋势分析

  • 按应用领域分類的市场份额，2024 年和 2033 年
  • 细分仪表板
  • 全球体液采集与诊断市场展望（按应用领域划分）
  • 市场规模、预测与趋势分析，2021-2033年
  • 诊断和监测
  • 治疗决策
  • 预后和筛检

第八章：体液采集与诊断市场：区域估算与趋势分析

  • 2024 年及 2033 年各地区市占率分析
  • 区域市场概览
  • 区域市场概况
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要企业市占率分析，2024 年
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories
    • Illumina, Inc
    • Guardant Health
    • QIAGEN
    • Johnson &Johnson
    • Laboratory Corporation of America Holdings
    • Biocept Inc
    • F. Hoffmann-La Roche Ltd.
    • MDxHealth SA.
Product Code: GVR-4-68040-019-8

Body Fluid Collection And Diagnostics Market Summary

The global body fluid collection and diagnostics market size was estimated at USD 34.35 billion in 2024 and is anticipated to reach USD 61.99 billion by 2033, growing at a CAGR of 6.87% from 2025 to 2033. Rapid results, cost-effectiveness, and early prognosis of diseases are some of the factors contributing to the growth of the body fluid collection and diagnostics industry.

Advances in in-vitro diagnostic techniques are also playing a big role, as they make testing more accurate and efficient, encouraging wider use. For instance, in May 2022, TECHKON GmbH introduced a new method for analyzing body fluids that can assess medical parameters and diagnose diseases at the same time, making testing faster and more comprehensive.

The growing number of blood-related disorders is a key factor driving the demand for blood collection devices. Diseases such as anemia, sickle cell disease, hemophilia, and clotting disorders are becoming more common, along with blood cancers such as myeloma, lymphoma, and leukemia. In the U.S., blood cancer is particularly devastating, taking a life every nine minutes, which adds up to about 157 deaths each day or more than six every hour. In 2023, it's estimated that nearly 57,380 people in the U.S. will die from leukemia, lymphoma, or myeloma, accounting for almost 9.4% of all cancer-related deaths.

An estimated 437,337 individuals in the U.S. are either living with or in remission from leukemia, while around 879,242 people are in the same condition with lymphoma. Blood clots affect approximately 900,000 Americans each year, leading to about 100,000 deaths annually. Notably, fewer than one in four people show any noticeable signs or symptoms of a blood clot, underscoring the silent but significant impact of this condition.

The growing focus on early disease detection has significantly driven demand in the body fluid collection and diagnostics industry. Samples such as saliva, blood, urine, and semen are increasingly used to analyze biomarkers and other indicators for accurate and timely diagnosis. Moreover, numerous advancements and innovations have been made globally, further enhancing testing capabilities and expanding the range of conditions that can be detected through fluid-based diagnostics. For instance, in July 2021, Abbott announced of launching Panbio COVID-19 Antigen Self-Test in India to strengthen its rapid diagnostics product portfolio. It would support testing needs at work, at clinics, and at home. Further recently, In May 2024, the U.S. FDA approved the Rika Plasma Donation System featuring the iNomi Nomogram developed by Terumo Corporation. This product helps determine plasma collection volume based on an individual donor's weight, height, and hematocrit level at the time of donation.

Alzheimer's Disease (AD) is a severe neurodegenerative disease that requires the identification of precise biomarkers. The development and validation of early-stage biomarkers is a high research priority for existing diagnostics that can detect AD. Body-fluid biomarkers accurately reflect a synaptic failure in the brain and, as a result, could help improve diagnostic accuracy, track the course of the disease, and act as indicators for evaluating the effectiveness of early-onset disease-modifying therapies. In May 2022, the FDA authorized the marketing of a new test that could improve the diagnosis of AD. The Lumipulse test evaluates the ratio of -amyloid 1-40 and-amyloid 1-42 concentrations found in the human cerebral spinal fluid, which can help doctors in determining if a patient is expected to have amyloid plaques, a characteristic symptom of AD.

Body fluid samples contain a large number of naturally occurring biomarker proteins, which effectively show cancer progression. They are also utilized to find these biomarkers in order to validate the presence of cancer. For instance, in January 2022, scientists from the University of Illinois developed a tool that could detect cancer biomarkers in the body fluid samples. The quantification and detection of cancer-associated molecular biomarkers in such body fluids would help for minimally invasive cancer detection.

Furthermore, technological innovations in in-vitro diagnostics, such as high-throughput testing, automation, and integration of AI, have significantly enhanced diagnostic accuracy and efficiency. These advancements enable faster turnaround times and improved sensitivity, making body fluid diagnostic tools indispensable for modern healthcare. The availability of such innovative solutions supports the global adoption of these technologies.

Global Body Fluid Collection And Diagnostics Market Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global body fluid collection and diagnostics market report on the basis of sample, technology, application, product and region:

  • Sample Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood
  • Saliva
  • Urine
  • Cerebrospinal Fluid
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Tests/Services
  • Kits & Consumables
  • Instruments
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence in situ hybridization (FISH)
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostics & Monitoring
  • Therapeutic Decision Making
  • Prognostics & Screening
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Sample
    • 1.2.2. Product
    • 1.2.3. Technology
    • 1.2.4. Application
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Sample Outlook
    • 2.2.2. Product outlook
    • 2.2.3. Technology outlook
    • 2.2.4. Application outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Body Fluid Collection And Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing adoption of body fluid and collection kits for rapid diagnosis
      • 3.2.1.2. Increasing prevalence of non-communicable diseases
      • 3.2.1.3. Technological Advancements in Diagnostic Testing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of expertise to conduct at-home testing
      • 3.2.2.2. High cost of instruments
  • 3.3. Body Fluid Collection And Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Body Fluid Collection And Diagnostics Market: Sample Estimates & Trend Analysis

  • 4.1. Sample Market Share, 2024 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Body Fluid Collection And Diagnostics Market by Sample Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Blood
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 4.6. Saliva
    • 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Urine
    • 4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.8. Cerebrospinal Fluid
    • 4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Body Fluid Collection And Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Product Market Share, 2024 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Body Fluid Collection And Diagnostics Market by Product Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Tests/Services
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 5.6. Kits & Consumables
    • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Instruments
    • 5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Body Fluid Collection And Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Market Share, 2024 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Body Fluid Collection And Diagnostics Market by Technology Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Next-Generation Sequencing
    • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 6.6. Polymerase Chain Reaction (PCR)
    • 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Fluorescence in situ hybridization (FISH)
    • 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Body Fluid Collection And Diagnostics Market: Application Estimates & Trend Analysis

  • 7.1. Application Market Share, 2024 & 2033
  • 7.2. Segment Dashboard
  • 7.3. Global Body Fluid Collection And Diagnostics Market by Application Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Diagnostics & Monitoring
    • 7.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 7.6. Therapeutic Decision Making
    • 7.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Prognostics & Screening
    • 7.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Body Fluid Collection And Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2021 to 2033, (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key company market share analysis, 2024
    • 9.3.2. Thermo Fisher Scientific Inc.
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Bio-Rad Laboratories
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Illumina, Inc
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Guardant Health
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. QIAGEN
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Johnson & Johnson
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Laboratory Corporation of America Holdings
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Biocept Inc
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. F. Hoffmann-La Roche Ltd.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. MDxHealth SA.
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 4 Global body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 5 Global body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 6 Global body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 7 North America body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 9 North America body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 10 North America body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 11 North America body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 12 U.S. body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 13 U.S. body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 14 U.S. body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 15 U.S. body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 16 Canada body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 17 Canada body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 18 Canada body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 19 Canada body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 20 Mexico body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 21 Mexico body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 22 Mexico body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 23 Mexico body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 24 Europe body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
  • Table 25 Europe body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 26 Europe body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 27 Europe body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 28 Europe body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 29 Germany body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 30 Germany body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 31 Germany body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 32 Germany body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 33 UK body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 34 UK body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 35 UK body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 36 UK body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 37 France body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 38 France body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 39 France body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 40 France body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 41 Italy body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 42 Italy body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 43 Italy body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 44 Italy body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 45 Spain body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 46 Spain body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 47 Spain body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 48 Spain body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 49 Denmark body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 50 Denmark body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 51 Denmark body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 52 Denmark body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 53 Sweden body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 54 Sweden body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 55 Sweden body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 56 Sweden body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 57 Norway body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 58 Norway body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 59 Norway body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 60 Norway body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 66 China body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 67 China body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 68 China body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 69 China body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 70 Japan body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 71 Japan body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 72 Japan body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 73 Japan body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 74 India body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 75 India body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 76 India body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 77 India body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 78 South Korea body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 79 South Korea body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 80 South Korea body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 81 South Korea body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 82 Australia body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 83 Australia body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 84 Australia body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 85 Australia body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 86 Thailand body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 87 Thailand body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 88 Thailand body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 99 Thailand body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 100 Latin America body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
  • Table 101 Latin America body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 102 Latin America body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 103 Latin America body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 104 Latin America body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 105 Brazil body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 106 Brazil body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 107 Brazil body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 108 Brazil body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 109 Argentina body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 110 Argentina body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 111 Argentina body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 112 Argentina body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 113 Middle East & Africa body fluid collection and diagnostics market, by Country, 2021 - 2033 (USD Million)
  • Table 114 Middle East & Africa body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 115 Middle East & Africa body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 116 Middle East & Africa body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 117 Middle East & Africa body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 118 South Africa body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 119 South Africa body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 120 South Africa body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 121 South Africa body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 122 Saudi Arabia body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 123 Saudi Arabia body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 124 Saudi Arabia body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 125 Saudi Arabia body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 126 UAE body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 127 UAE body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 128 UAE body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 130 UAE body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 131 Kuwait body fluid collection and diagnostics market, by Sample, 2021 - 2033 (USD Million)
  • Table 132 Kuwait body fluid collection and diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 133 Kuwait body fluid collection and diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 134 Kuwait body fluid collection and diagnostics market, by Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Body Fluid Collection And Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global body fluid collection and diagnostics market, Sample Movement Analysis
  • Fig. 16 Global body fluid collection and diagnostics market, for Blood, 2021 - 2033 (USD Million)
  • Fig. 17 Global body fluid collection and diagnostics market, for Urine, 2021 - 2033 (USD Million)
  • Fig. 18 Global body fluid collection and diagnostics market, for Saliva, 2021 - 2033 (USD Million)
  • Fig. 19 Global body fluid collection and diagnostics market, for Cerebrospinal Fluid, 2021 - 2033 (USD Million)
  • Fig. 20 Global body fluid collection and diagnostics market, Product Movement Analysis
  • Fig. 21 Global body fluid collection and diagnostics market, for Tests/Services, Movement Analysis
  • Fig. 22 Global body fluid collection and diagnostics market, for Kits & Consumables, 2021 - 2033 (USD Million)
  • Fig. 23 Global body fluid collection and diagnostics market, for Instruments, 2021 - 2033 (USD
  • Fig. 24 Global body fluid collection and diagnostics market, Technology Movement Analysis
  • Fig. 25 Global body fluid collection and diagnostics market, for Next Generation Sequencing, 2021 - 2033 (USD Million)
  • Fig. 26 Global body fluid collection and diagnostics market, for PCR - based Testing, 2021 - 2033 (USD Million)
  • Fig. 27 Global body fluid collection and diagnostics market, for FISH, 2021 - 2033 (USD Million)
  • Fig. 28 Global body fluid collection and diagnostics market, for Others, 2021 - 2033 (USD Million)
  • Fig. 29 Global body fluid collection and diagnostics market, Application Movement Analysis
  • Fig. 30 Global body fluid collection and diagnostics market, for Diagnostics & Monitoring, 2021 - 2033 (USD Million)
  • Fig. 31 Global body fluid collection and diagnostics market, for Therapeutic Decision Making, 2021 - 2033 (USD Million)
  • Fig. 32 Global body fluid collection and diagnostics market, for Prognostics & Screening, 2018- 2033 Million)
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 Regional Outlook, 2024 & 2033
  • Fig. 35 Global Body Fluid Collection And Diagnostics Market, Region Movement Analysis
  • Fig. 36 North America body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 38 Canada body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 39 Mexico body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 40 Europe body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 41 Germany body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 42 UK body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 43 France body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 44 Italy body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 46 Denmark body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 48 Norway body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 49 Asia Pacific body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 50 Japan body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 51 China body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 52 India body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 53 Australia body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 54 South Korea body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 55 Thailand body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 56 Latin America body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 57 Brazil body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 58 Argentina body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 59 Middle East and Africa body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 60 South Africa body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 62 UAE body fluid collection and diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 63 Kuwait body fluid collection and diagnostics market, 2021 - 2033 (USD Million)